Cargando…
Intravitreal Therapy for Diabetic Macular Edema: An Update
Diabetic macular edema (DME) represents a prevalent and disabling eye condition. Despite that DME represents a sight-threatening condition, it is also among the most accessible to treatment. Many different treatment options including photocoagulation, intravitreal medical treatment (either vascular...
Autores principales: | Furino, Claudio, Boscia, Francesco, Reibaldi, Michele, Alessio, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925023/ https://www.ncbi.nlm.nih.gov/pubmed/33688431 http://dx.doi.org/10.1155/2021/6654168 |
Ejemplares similares
-
Efficacy of Intravitreal Dexamethasone Implant in Different Patterns of Diabetic Macular Edema
por: Furino, Claudio, et al.
Publicado: (2020) -
DIABETIC MACULAR EDEMA AND CATARACT SURGERY: Phacoemulsification Combined With Dexamethasone Intravitreal Implant Compared With Standard Phacoemulsification
por: Furino, Claudio, et al.
Publicado: (2021) -
Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema
por: Furino, Claudio, et al.
Publicado: (2017) -
Intravitreal Injections in Arc Sterile Setting: Safety Profile after More Than 10,000 Treatments
por: Furino, Claudio, et al.
Publicado: (2020) -
Intravitreal DEX Implant for the Treatment of Diabetic Macular Edema: A Review of National Consensus
por: Spinetta, Roberta, et al.
Publicado: (2023)